Company
At Neuromod, we are committed to stimulating progress through the design, clinical validation and commercialisation of neuromodulation technologies.
Stimulating progress
At Neuromod, we are committed to stimulating progress through the design, clinical validation and commercialisation of neuromodulation technologies.
Stimulating leadership
Our management and board share a commitment towards achieving significant breakthroughs in the field of bi-modal neuromodulation. Together, we bring our collective skills, talents and experience to bear on the pursuit of this ambitious endeavour.
Ross is a biomedical engineer with a personal passion for developing neuromodulation therapies for hearing and auditory system disorders. He founded Neuromod in 2010 to develop non-invasive neuromodulation treatments for chronic neurological disorders.
Manus is a chemist who began his career in drug development before moving into business development and venture capital investment, establishing Fountain Healthcare Partners in the 2000’s to invest in groundbreaking technologies in the life science sector.
We are proud to be working with a number of partners who share and respect our vision of this game-changing therapeutic breakthrough.